Publishing research using ab31324? Please let us know so that we can cite the reference in this datasheet.

ab31324 has been referenced in 1 publication.

  • Chase A  et al. Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome. Haematologica 98:103-6 (2013). WB ; Human . PubMed: 22875613

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"